Purchase Order HHSN272201400878P
Award Date 8/15/14
Potential Completion Date 8/20/14
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of TruSeq sequencing kits. The contract, valued at $12,697.30, has no set-aside designation and is for the ultimate completion of the order by September 5, 2014. Illumina, a manufacturer of sequencing and array-based genomic analysis instruments and reagents, has a history of providing...
- This is a federal purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of TruSeq sequencing kits. The $5,610 firm fixed price award has a completion date of September 12, 2014 and does not utilize any set-aside provisions. Illumina is a manufacturer of genomic sequencing instruments and reagents, and has previously supported genomic research and diagnostic projects...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the purchase of TruSeq sequencing kits. The order, valued at $8,623.90, does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies like the National Institutes of Health,...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The $21,164.66 fixed-price contract is for the purchase of Illumina TruSeq sequencing kits. No set-aside provisions were used. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has previously supported genomic research and diagnostics needs across various federal agencies including NIH,...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $3,938.22 firm fixed price purchase order is for the delivery of sequencing kits, with a completion date of September 14, 2015. The contract has no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and...
- The U.S. Department of Health and Human Services, National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price delivery order contract to Illumina, Inc. for the provision of TRU SEQ kits. The contract has a ceiling value of $5,503.72 and a period of performance ending on March 22, 2016. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has previously received other federal contract and sub-contract...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $5,626.82 firm fixed price delivery order is for the purchase of Illumina's TruSeq SBS Kit v3 - HS - 50-Cycle, which supports high-throughput DNA sequencing. The award has no set-aside designation and appears to align with NIAID's mission to support...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genetic and genomic analysis equipment and reagents, for TruSeq kits. The order has a potential value of $28,330.30 and a completion date of August 8, 2017. The contract does not have a set-aside designation. Illumina has previously received other federal contract awards from...
- This firm fixed-price delivery order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), an agency within the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $8,366.17 award is for the procurement of Illumina's TruSeq DNA Sample Prep Kit Set A, which supports sample preparation for genomic sequencing. Illumina has a history of prime federal contract and subcontract...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), to Illumina, Inc. for the procurement of Illumina TruSeq kits. The $12,697.30 firm fixed price purchase order did not have a set-aside designation. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents, and has previously provided sequencing systems, reagents, and related services to various federal...